Incannex Healthcare Inc. (IXHL): Share Repurchases

Annual figures by period end, from SEC filings.

$9.40M
Year ended 2026-06-30
2025-06-30: $02026-06-30: $9.40M$9.40M
2025-06-30 Share Repurchases (USD) 2026-06-30
Period endedShare RepurchasesChange YoYSource filing
2026-06-30$9.40Mn/a2026-09-25, From 2025-07-01
2025-06-30$0n/a2026-09-25, From 2024-07-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Incannex Healthcare Inc. (IXHL)2026-06-30$9.40Mn/a
Abbott Laboratories (ABT)2025-12-31$893.00M-31.0%
Bristol Myers Squibb Co (BMY)2025-12-31$0n/a
Eli Lilly & Co (LLY)2025-12-31$4.11B+64.3%
Johnson & Johnson (JNJ)2025-12-28$5.95B+144.8%
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
Merck & Co., Inc. (MRK)2025-12-31$5.08B+289.3%
Lifevantage Corp (LFVN)2026-06-30$2.04M-35.1%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$3.44B+32.1%

Compare IXHL, ABT, BMY, LLY side by side · Screen every company in Pharmaceutical Preparations ↗